Atlas Trials

Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin

Clinical trial NCT03736720 · TERMINATED

Trial details

NCT number
NCT03736720
Sponsor
Roswell Park Cancer Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Locally Advanced Digestive System Neuroendocrine CarcinomaLocally Advanced Pancreatic Neuroendocrine CarcinomaMetastatic Digestive System Neuroendocrine CarcinomaMetastatic Pancreatic Neuroendocrine CarcinomaRefractory Digestive System Neuroendocrine CarcinomaRefractory Pancreatic Neuroendocrine CarcinomaUnresectable Digestive System Neuroendocrine CarcinomaUnresectable Pancreatic Neuroendocrine Carcinoma
Start date
2019-06-17
Primary completion
2022-10-18
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.